Patient-Centered Outcomes Research Institute: Cycle 1 2020 Award Amount: $3 million for small studies; $5 million for large studies The Broad PCORI Funding Announcements (PFAs) seek investigator-initiated applications for patient-centered comparative clinical effectiveness research (CER) projects aligned with our priority areas for research. This PFA covers the following four priority areas: Addressing Disparities; Assessment of Prevention, Diagnosis, and Treatment Options; Communication and Dissemination Research, and Improving Healthcare Systems. Applications should address needs of patients, caregivers, clinicians, and other healthcare stakeholders in making personalized clinical decisions across a wide range of conditions, populations, and treatments. Note: In general, PCORI will not cover costs for interventions that are being compared in the proposed study. View the complete RFP here. If you are interested in applying, please reach out to Lynn Wong or Gwen Allouch with the Office of Advancement.
Application Due Date: February 4, 2020
These broad areas encompass the patient-centered comparative clinical effectiveness research we support. As our work progresses and we engage with a broad range of patients, caregivers, clinicians, and other healthcare stakeholders, we may develop additional national priorities for research.
PCORI’s reauthorizing legislation provided additional direction about national research priorities, noting that they should include research with respect to intellectual and developmental disabilities and maternal mortality.
For this cycle, PCORI has also included the following Research Areas of Interest: genetic sequencing to guide cancer treatment, peripheral artery disease, and suicide prevention. The goal of calling these out is to encourage submissions on these topics and priorities, not to limit submissions to these topics.